Skip to content
WeighLab

MedLeanRx vs LaSara Medical Group

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MedLeanRx

Provider comparison

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Semaglutide / month
$149/moCompounded oral
Tirzepatide / month
$269/moCompounded
Index 58/100 · Grade CChecked August 2026

LaSara Medical Group

Provider comparison

Shoppers who want a hybrid in-person/telehealth GLP-1 option in Southern California and are comfortable prepaying a year for the lowest rate.

Semaglutide / month
$289/moCompounded monthly subscription; $299 one-month purchase
Tirzepatide / month
$379/moCompounded monthly subscription; $399 one-month purchase
Index 58/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 58/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

MedLeanRx
1 state
LaSara Medical Group
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MedLeanRx

LaSara Medical Group

Semaglutide / month
MedLeanRx: $149/moCompounded oral
LaSara Medical Group: $289/moCompounded monthly subscription; $299 one-month purchase
Tirzepatide / month
MedLeanRx: $269/moCompounded
LaSara Medical Group: $379/moCompounded monthly subscription; $399 one-month purchase
Semaglutide / year (modeled)
MedLeanRx: $1,788
LaSara Medical Group: $3,468
Tirzepatide / year (modeled)
MedLeanRx: $3,228
LaSara Medical Group: $4,548
State availability
MedLeanRx: 1 state
LaSara Medical Group: Coverage not published
Oral / sublingual option listed
MedLeanRx: Yes
LaSara Medical Group: Not listed
Brand-name access listed
MedLeanRx: Yes
LaSara Medical Group: Not confirmed
Provider facts checked
MedLeanRx: August 2026
LaSara Medical Group: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MedLeanRx

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Reasons to consider it

  • Named supervising physician (Dr. Johnson Uzor, MD) publicly disclosed with a dedicated bio page
  • Both compounded semaglutide (injectable and oral tablet) and a brand Wegovy/Zepbound/Foundayo pathway offered on one platform
  • Flat pricing with no dose-tier escalation disclosed

What to weigh up

  • Texas only — not available in any other state
  • Compounding pharmacy is never named anywhere on the site
  • The Terms & Conditions state 'All sales are final' — no refund policy

LaSara Medical Group

Shoppers who want a hybrid in-person/telehealth GLP-1 option in Southern California and are comfortable prepaying a year for the lowest rate.

Reasons to consider it

  • Full, clean 4-tier pricing tables published for both drugs with exact dollar totals at every commitment length — real transparency, no gating behind intake
  • Named clinical leadership: Medical Director Dr. Sunil Kurup and Founder/CEO John Snedegar
  • Rare hybrid model — national telehealth plus an actual in-person Southern California option, alongside a broader hormone/peptide menu (TRT, NAD+, sermorelin, B12, enclomiphene)

What to weigh up

  • Lower monthly equivalents require three, six or twelve months paid upfront
  • A one-month purchase costs $299 semaglutide or $399 tirzepatide; recurring subscriptions cost $289/$379
  • The pricing pages do not list covered states or name the dispensing pharmacy

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MedLeanRxLaSara Medical Group
Normalized Cost/Month
MedLeanRx:
31/100
LaSara Medical Group:
47/100
Price Transparency
MedLeanRx:
78/100
LaSara Medical Group:
86/100
Nationwide Access
MedLeanRx:
42/100
LaSara Medical Group:
24/100
Formulation Options
MedLeanRx:
90/100
LaSara Medical Group:
66/100
Clinical Oversight
MedLeanRx:
77/100
LaSara Medical Group:
78/100
Contract Flexibility
MedLeanRx:
47/100
LaSara Medical Group:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.